Back

Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.

30 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Adipose tissue and other metabolic interactions Metabolism ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)

8 More presentations in this session

Presentation thumbnail
Pericardial adipose tissue (PAT) as a cell model to assess patient responsiveness to docosahexaenoic acid (DHA) and eicopentaenoic acid (EPA)
Doctor S. Quarta (Lecce, IT)
Abstract Slides
Presentation thumbnail
Novel role of human epicardial adipocyte-derived SPARCL1 in suppression of postoperative atrial fibrillation in patients undergoing cardiovascular surgery
Doctor T. Harada (Yufu City, JP)
Abstract Slides
Presentation thumbnail
Genetically Engineered Clostridium Prevents Perivascular Adipose Tissue and Endothelial Senescence and Dysfunction in Aging
Doctor S. Saeedi (Schlieren, CH)
Abstract Slides
Presentation thumbnail
Secretomes from human epicardial adipocytes modulate atrial lymphatics and atrial fibrosis
Doctor M. Takahashi (Oita, JP)
Abstract Slides
Presentation thumbnail
Epigenetic modifications in transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells
Mr Y. Shinjo (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Adipose tissue and other metabolic interactions

The Event

Event poster

ESC Congress 2024

30 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation
thumbnail
Congress Presentation
Adipose and non-adipose layers of epicardium: paracrine activity consequences on cardiomyocytes and modulation by semaglutide
thumbnail
Congress Presentation
Evaluation of tricuspid annular plane systolic excursion and epicardiac adipose tissue in patients with type 2 diabetes treated with oral semaglutide

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources